Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design

BACKGROUND: Following universal recommendation for use of 13-valent pneumococcal conjugate vaccine (PCV13) in US adults aged ≥65 years in September 2014, we conducted the first real-world evaluation of PCV13 vaccine effectiveness (VE) against hospitalized vaccine-type community-acquired pneumonia (C...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: McLaughlin, John M, Jiang, Qin, Isturiz, Raul E, Sings, Heather L, Swerdlow, David L, Gessner, Bradford D, Carrico, Ruth M, Peyrani, Paula, Wiemken, Timothy L, Mattingly, William A, Ramirez, Julio A, Jodar, Luis
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Articles and Commentaries
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206101/
https://ncbi.nlm.nih.gov/pubmed/29790925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy312
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars